Allison P. Kann (ORCID 0000-0003-0111-9081) has 22 indexed works, ~279 total citations, and an h-index of 7, with citation counts accelerating from ~6 in 2015 to 113 in 2022, driven primarily by her first-author Cell Stem Cell paper on an injury-responsive Rac-to-Rho GTPase switch in muscle stem cells (~90 citations) and a methods paper on multiplexed RNAscope/immunofluorescence in myofibers (~53 citations) .
In the eLife Hofstenia miamia study, Kann contributed to work with strong quantitative foundations: 42 tracked zygotes, organ-size regressions with RΒ² of 0.63β0.84 (all p < 0.001), and openly deposited data and code on Zenodo . The companion Nature Communications wound-closure work demonstrates mechanistic depth via inhibitor experiments (blebbistatin, tricaine) and one-way ANOVA with Dunnett's correction, though author-reported limitations include mounting imperfections and uncertain ECM substrate localization .
The Hofstenia work is single-species, laboratory-only, with modest sub-analysis sample sizes and observational behavioral data limiting causal inference about environmental cues; generalization to wild populations remains untested. The wound-closure paper lacks a single reported analyzed N and combined bridge-length reporting due to assignment difficulties. Both are recent (2026) with minimal citations yet, so long-term impact is genuinely unknown rather than assessable. Kann's open-access habits (7/7 works OA in 2025, gold OA on key papers) and no competing-interest declarations are positive integrity signals.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.